Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	86.79	50.19	55.14	97.47	79.51	164.89
Short-Term Investments	205.95	285.88	202.96	326.68	446.73	285.61
Cash & Short-Term Investments	292.74	336.08	258.11	424.15	526.24	450.5
Cash Growth	-22.10%	30.21%	-39.15%	-19.40%	16.81%	50.48%
Accounts Receivable	62.49	84.76	69.02	51.13	52.75	139.15
Other Receivables	6.68	6.85	8.01	6.31	22.36	4.15
Receivables	69.17	91.61	77.03	57.45	75.11	143.3
Prepaid Expenses	7.44	5.1	6.63	7.74	6.81	4.24
Other Current Assets	13.73	117.7	11.81	18.5	19.71	13.92
Total Current Assets	383.74	550.49	353.57	507.85	627.87	611.96
Property, Plant & Equipment	118.87	117.85	111.72	95.62	98.92	71.16
Long-Term Investments	374.55	384.27	595.28	444.01	339.03	507.01
Goodwill	53.86	25.08	22.06	22.06	143.03	50.9
Other Intangible Assets	146.8	133.28	134.98	143.05	150.64	35.91
Long-Term Deferred Tax Assets	-	-	-	-	3.5	0.76
Other Long-Term Assets	1.12	2.56	2.37	22.75	23.05	1.02
Total Assets	1,079	1,214	1,220	1,235	1,386	1,279

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	16.97	18.65	18.36	15.36	23.09	20.49
Accrued Expenses	19.87	32.24	22.44	26.24	17.91	15.52
Short-Term Debt	-	-	-	-	15	21.28
Current Portion of Long-Term Debt	0.48	0.48	0.41	1.18	5.64	-
Current Portion of Leases	2.2	1.82	1.84	4.5	7.08	2.17
Current Income Taxes Payable	-	-	-	-	-	0.79
Current Unearned Revenue	2.62	3.64	2.23	2.87	3.2	14.57
Other Current Liabilities	29.73	28.15	27.61	22.86	16.2	30.49
Total Current Liabilities	71.88	84.97	72.9	73.02	88.11	105.31
Long-Term Debt	1.48	1.96	2.49	2.96	-	-
Long-Term Leases	6.21	3.78	4.48	7.91	10.61	6.74
Long-Term Deferred Tax Liabilities	6.96	6.94	6.37	7.96	-	-
Other Long-Term Liabilities	7.7	9.17	4.56	10.19	17.46	0.79
Total Liabilities	94.22	106.81	90.81	102.04	116.18	112.84

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	531.56	574.52	543.13	501.72	486.59	501.91
Retained Earnings	462.45	529.95	590.47	633.18	801	657.6
Comprehensive Income & Other	-3.53	7.51	-0.37	1.21	-20.9	-0.76
Total Common Equity	990.49	1,112	1,133	1,136	1,267	1,159
Minority Interest	-5.78	-5.27	-4.07	-2.82	3.19	7.13
Shareholders' Equity	984.71	1,107	1,129	1,133	1,270	1,166
Total Liabilities & Equity	1,079	1,214	1,220	1,235	1,386	1,279

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	10.37	8.04	9.23	16.56	38.33	30.2
Net Cash (Debt)	641.92	697.31	819.23	831.17	814.56	905.35
Net Cash Growth	-17.66%	-14.88%	-1.44%	2.04%	-10.03%	117.48%
Net Cash Per Share	21.85	22.66	27.10	27.91	26.31	29.23
Filing Date Shares Outstanding	27.94	31.23	30.83	29.78	29.52	30.25
Total Common Shares Outstanding	27.76	31.08	30.84	29.65	29.44	30.16
Working Capital	311.86	465.52	280.67	434.83	539.77	506.65
Book Value Per Share	35.68	35.78	36.74	38.31	43.03	38.42
Tangible Book Value	789.83	953.63	976.2	970.99	973.02	1,072
Tangible Book Value Per Share	28.45	30.68	31.65	32.75	33.05	35.54
Land	17.35	17.35	17.35	8.8	7.5	7.5
Buildings	57.56	54.89	49.61	17.53	12.6	10.67
Machinery	87.47	80.71	76.07	73.65	71.97	51.22
Leasehold Improvements	4.51	4.47	3.32	11.22	11.8	4

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Nov 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error